LacriJet® is FCI latest and exclusive preloaded & self-retaining monocanalicular nasolacrimal intubation indicated for epiphora, congenital nasolacrimal duct obstruction and canalicular laceration. LacriJet® consists of a single use injector handpiece into which a silicone tube is preloaded inside a metallic guide. Its special design enables to reduce operating time, either in the intubation phase as well as for the removal of the device.
We would like to thank B. Fayet, M.D, Paris, France, for his contribution to this video.
Learn more at:
🌐 fciworldwide.com/products/lac...
🇺🇸 fci-ophthalmics.com/products/...
Follow us on LinkedIn:
🖥️ / fci-ophthalmics